Skip to Content

Which patient is most likely to have Addison’s disease?

Addison’s disease, also known as primary adrenal insufficiency, is a rare endocrine disorder characterized by insufficient production of cortisol and aldosterone by the adrenal glands. Determining which patient is most likely to have Addison’s disease requires a thorough understanding of the disease itself as well as careful analysis of each patient’s signs, symptoms, medical history, and diagnostic test results.

Overview of Addison’s Disease

In healthy individuals, the adrenal glands produce vital hormones including cortisol and aldosterone. Cortisol regulates metabolism and the body’s response to stress, while aldosterone regulates sodium and water balance in the body. In Addison’s disease, the adrenal glands are damaged and unable to produce adequate amounts of these essential hormones.

There are two main types of Addison’s disease:

  • Primary adrenal insufficiency: This is caused by damage to the adrenal glands themselves. It can occur due to autoimmune disorders, infections, adrenal hemorrhage, or metastatic cancers.
  • Secondary adrenal insufficiency: This is caused by a lack of ACTH, the hormone from the pituitary gland that stimulates cortisol production. It can occur when the pituitary gland is damaged or diseased.

Without enough cortisol and aldosterone, patients experience a constellation of nonspecific symptoms that can include:

  • Fatigue
  • Muscle weakness
  • Weight loss
  • Joint and abdominal pain
  • Salt craving
  • Low blood pressure
  • Hypoglycemia

In addition, low aldosterone causes an increase in urine output and electrolyte abnormalities. Laboratory findings consistent with Addison’s disease include hyponatremia, hyperkalemia, and high ACTH levels as the pituitary gland tries to stimulate more cortisol production.

Without treatment, an Addisonian crisis can occur involving severe dehydration, low blood pressure, kidney failure, and death. Therefore, early recognition and treatment of Addison’s disease is imperative.

Key Features of Addison’s Disease

When evaluating which patient among several may have Addison’s disease, it is important to look for the key features that point to adrenal insufficiency:

  • Hyperpigmentation: Increased production of ACTH leads to increased production of MSH which causes generalized hyperpigmentation. This appears as dark freckles on sun-exposed areas and gums.
  • Hypotension: Low aldosterone causes salt-wasting and volume depletion, resulting in low blood pressure.
  • Hyperkalemia: The kidney retains potassium due to low aldosterone levels.
  • Hyponatremia: Sodium levels fall due to lack of aldosterone.
  • Hypoglycemia: Low cortisol levels can impair regulation of glucose metabolism.
  • High plasma ACTH: Levels rise as pituitary increases stimulation of the impaired adrenal glands.
  • Low cortisol: Impaired adrenal function leads to insufficient cortisol production.

No single lab value or clinical feature confirms Addison’s disease. However, the combination of multiple findings consistent with adrenal insufficiency, especially in the appropriate clinical context, points strongly towards this diagnosis. The patient exhibiting the greatest number of characteristic features is most likely to have the disease.

Case Examples

To illustrate how to determine which patient is most likely to have Addison’s disease, let us consider the following 3 hypothetical patients:

Patient 1

  • 35 year old female
  • Complaints of fatigue, nausea, and weight loss over past 2 months
  • Medical history: Autoimmune hypothyroidism
  • Medications: Levothyroxine
  • Vital signs: Blood pressure 90/60 mm Hg, heart rate 92 bpm
  • Physical exam: Hyperpigmentation on gums, lips, and skin folds
  • Laboratory:
    • Sodium 125 mEq/L (normal 135-145)
    • Potassium 5.5 mEq/L (normal 3.5-5.0)
    • Morning cortisol 2.5 mcg/dL (normal 6-23)
    • ACTH 250 pg/mL (normal less than 46)

Patient 2

  • 27 year old male
  • Complaints of abdominal pain, nausea, vomiting, and weight loss over past 5 months
  • Medical history:
    • Tuberculosis 2 years ago, treated
    • HIV positive
  • Vital signs: Blood pressure 100/70 mm Hg, heart rate 88 bpm
  • Physical exam: No hyperpigmentation
  • Laboratory:
    • Sodium 133 mEq/L (normal 135-145)
    • Potassium 4.2 mEq/L (normal 3.5-5.0)
    • Morning cortisol 8 mcg/dL (normal 6-23)
    • ACTH 45 pg/mL (normal less than 46)

Patient 3

  • 52 year old female
  • Complaints of fatigue and muscle weakness
  • Medical history: Breast cancer, treated with mastectomy and chemotherapy 2 years ago
  • Vital signs: Blood pressure 118/78 mm Hg, heart rate 76 bpm
  • Physical exam: No hyperpigmentation
  • Laboratory:
    • Sodium 141 mEq/L (normal 135-145)
    • Potassium 4.8 mEq/L (normal 3.5-5.0)
    • Morning cortisol 12 mcg/dL (normal 6-23)
    • ACTH 32 pg/mL (normal less than 46)

Given these three patient cases, which one is most likely to have Addison’s disease?


To determine which patient is most likely to have Addison’s disease, we need to analyze the key clinical and laboratory findings for each patient and see who best fits the typical profile of adrenal insufficiency.

It is helpful to visualize the pertinent data for each patient in a table:

Finding Patient 1 Patient 2 Patient 3
Hyperpigmentation Yes No No
Hypotension Yes No No
Hyperkalemia Yes No No
Hyponatremia Yes Mild No
Hypoglycemia Not assessed Not assessed Not assessed
High ACTH Yes No No
Low cortisol Yes No No

Based on this analysis, Patient 1 has the most clinical and laboratory abnormalities consistent with Addison’s disease – namely hyperpigmentation, hypotension, hyperkalemia, hyponatremia, high ACTH, and low cortisol. Patient 2 and Patient 3 show at most only one finding potentially linked to adrenal insufficiency. Therefore, Patient 1 is the most likely to have Addison’s disease.


Determining which patient is most likely to have Addison’s disease requires a systematic approach analyzing all the clinical features and laboratory data for evidence of adrenal insufficiency. Although no one finding confirms the diagnosis, the combination of multiple characteristic findings including hyperpigmentation, hypotension, electrolyte abnormalities, high ACTH, and low cortisol levels points to the highest probability. Of the three patients presented, Patient 1 exhibits the greatest number of typical abnormalities and is most likely to have Addison’s disease. The dramatic symptoms and laboratory derangements warrant urgent treatment with steroid replacement for this patient while pursuing confirmation of the diagnosis with additional testing such as ACTH stimulation.

In evaluating which patient may have this rare endocrine disorder, it is crucial to look at the full clinical and biochemical picture. The patient with the most features classic for primary adrenal failure stands out as the one most likely to have Addison’s disease. With prompt diagnosis and treatment, the morbidity and potential mortality from this disease can be avoided.

Additional Details on Addison’s Disease

Addison’s disease is uncommon, with a prevalence of around 1 in 100,000 people. Because symptoms are nonspecific and mimic many other conditions, diagnosis is often delayed with an average time from symptom onset to diagnosis of around 12 months. A high index of suspicion is required to recognize Addison’s disease early. Risk factors for the disease include autoimmune disorders, infections like TB and HIV, adrenal metastases, and adrenal hemorrhage. Autoimmune Addison’s disease may occur alongside other endocrine disorders like Hashimoto’s thyroiditis and Type 1 diabetes mellitus as part of the polyglandular autoimmune syndromes (APS I and II).

To confirm Addison’s disease, additional laboratory tests beyond the screening labs may be warranted such as:

  • Plasma renin activity – levels are elevated in Addison’s disease
  • Aldosterone – levels are low
  • Adrenal antibodies – may be present in autoimmune cases
  • ACTH stimulation test – inadequate cortisol response
  • Abdominal imaging – may show small, calcified adrenal glands

However, treatment should not be delayed while awaiting confirmation. Treatment involves lifelong glucocorticoid (hydrocortisone) and mineralocorticoid (fludrocortisone) replacement. With appropriate treatment and monitoring, patients can expect an excellent prognosis and normal longevity. Patient education regarding stress dosing of steroids and emergency injection kits is imperative.

In summary, Addison’s disease is an uncommon but life-threatening disorder requiring clinical vigilance for prompt diagnosis. Careful analysis of the history, exam, and laboratory findings of patients with suspected adrenal insufficiency allows identification of the individual most likely to have this disease so that treatment can be expedited.


Here is some more detail on the epidemiology of Addison’s disease:

  • Prevalence is estimated at around 40-110 cases per million population.
  • Incidence is about 4-6 new cases per million per year.
  • Onset is typically between ages 30-50 but can occur at any age.
  • It is slightly more common in women with some studies showing a female:male ratio of 1.4-1.7:1.
  • No major differences among ethnic groups have been found.

Geographic variations in prevalence likely reflect differences in frequencies of underlying etiologies. In developed countries, autoimmune disease likely accounts for up to 80% of cases. Infections like tuberculosis and HIV are more common causes in the developing world. Addison’s disease may account for up to 7.5% of primary adrenal insufficiency cases worldwide.

Autoimmune Pathogenesis

Since autoimmune Addison’s disease is the most common form, especially in developed countries, more details on the autoimmune pathogenesis are warranted:

  • Cytotoxic T lymphocytes and autoantibodies target and destroy the adrenal cortex.
  • Genetic HLA associations exist – mainly HLA-B8, HLA-DR3, HLA-DR4.
  • Adrenal cortex enzymes 21-hydroxylase (21-OH) and 17α-hydroxylase are common autoantigens.
  • Autoantibodies to these enzymes can be measured to confirm diagnosis.
  • Dysregulation of regulatory T cells may play a role.
  • Inflammation and autoantibody production ultimately lead to adrenal failure.

The autoimmune destruction is gradual over years, leading to varying degrees of adrenal impairment before manifestation of overt Addison’s disease. This explains why other autoimmune disorders may present before adrenal failure becomes clinically apparent in those genetically predisposed.

Diagnostic Evaluation

The diagnostic work-up for suspected Addison’s disease may include:

  • Early morning cortisol and ACTH levels
  • Electrolytes including sodium and potassium
  • Blood glucose
  • Renin and aldosterone levels
  • Adrenal gland antibodies
  • ACTH stimulation test
  • Abdominal CT scan of adrenals
  • Chest imaging if tuberculosis suspected

Imaging of the adrenal glands may show small shrunken glands with calcifications in long-standing cases. Biochemical testing can confirm adrenal insufficiency but does not indicate the underlying cause. Testing for infectious diseases like HIV or TB may be warranted in certain cases.

Treatment Considerations

Treatment involves replacing the deficient cortisol and aldosterone. This typically includes:

  • Hydrocortisone (10-15 mg/m2/day orally divided into 2-3 doses)
  • Fludrocortisone (0.05-0.2 mg/day)
  • Patient education on stress dosing and emergency injections
  • Monitoring electrolytes, blood pressure, glucose
  • Treating underlying autoimmune conditions or infections
  • Family genetic screening in autoimmune cases

With treatment, patients can expect normal life expectancy. The goals are to provide sufficient steroids to prevent adrenal crisis while avoiding excess replacement. Patients should be equipped with injectable steroids and educated on appropriate stress dosing to avert crises.


In summary key points regarding Addison’s disease include:

  • Rare endocrine disorder caused by adrenal insufficiency
  • Nonspecific symptoms make early diagnosis challenging
  • High index of suspicion required in appropriate clinical context
  • Autoimmune etiology accounts for most cases in developed countries
  • Diagnosis rests on biochemical evidence of adrenal hypofunction
  • Lifelong steroid replacement is mainstay of treatment
  • With treatment, prognosis is good

Careful evaluation for clinical and biochemical hallmarks of adrenal failure allows identification of those patients most likely to have Addison’s disease so that timely therapy can be initiated.